Profile
Vic Myer is currently the Director at KromaTid, Inc. and an Advisor at Atlas Venture Advisors, Inc. Previously, he held the position of Executive Director at Novartis AG from 2004 to 2015.
He also served as the Director, Head-Developmental & Molecular Pathways at Biomedical Research, Inc. Additionally, Dr. Myer was the Chief Technology Officer at Editas Medicine, Inc. from 2015 to 2019.
He was a Board Member at Standards Coordinating Body from 2018 to 2020.
Dr. Myer is the President & Chief Scientific Officer at Chroma Medicine, Inc. Dr. Myer obtained a doctorate degree from Yale University in 1995 and an undergraduate degree from Cornell University in 1989.
Vic Myer active positions
| Companies | Position | Start |
|---|---|---|
KromaTid, Inc.
KromaTid, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Director/Board Member | 2020-09-20 |
Atlas Venture Advisors, Inc.
Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors invests in companies located in the United States. The firm focuses on life sciences and biotech sectors. It provides financing for early stage capital requirements. | Consultant / Advisor | - |
Former positions of Vic Myer
| Companies | Position | End |
|---|---|---|
Standards Coordinating Body
Standards Coordinating Body The Standards Coordinating Body is a nonprofit organization focused on accelerating the development, awareness, and implementation of standards and best practices in regenerative medicine, gene and cell therapies, and cell-based drug discovery. The private company is based in Gaithersburg, MD. It engages stakeholders such as government agencies, researchers, manufacturers, clinicians, and industry suppliers to identify, prioritize, and advance standards that improve the consistency, quality, safety, and efficacy of regenerative medicine products. The organization facilitates collaboration through project working groups that develop feasibility studies, standards drafts, white papers, and coordinate data generation activities in areas including cell therapy, gene therapy, tissue engineering, and cell-based drug discovery. It offers specialized educational programs and resources, such as training on FDA-recognized ISO cell counting standards, an interactive database of standards, and educational materials. | Director/Board Member | 2020-06-30 |
| EDITAS MEDICINE, INC. | Chief Tech/Sci/R&D Officer | 2019-10-06 |
| NOVARTIS AG | Director/Board Member | 2015-04-29 |
Chroma Medicine, Inc.
Chroma Medicine, Inc. Pharmaceuticals: MajorHealth Technology Manufactures genomic medicines | President | - |
Biomedical Research, Inc.
Biomedical Research, Inc. BiotechnologyHealth Technology Provides biomedical research services | Corporate Officer/Principal | - |
Training of Vic Myer
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
KromaTid, Inc.
KromaTid, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Novartis AG
Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Atlas Venture Advisors, Inc.
Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors invests in companies located in the United States. The firm focuses on life sciences and biotech sectors. It provides financing for early stage capital requirements. | Finance |
Yale University
Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cornell University
Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biomedical Research, Inc.
Biomedical Research, Inc. BiotechnologyHealth Technology Provides biomedical research services | Health Technology |
Editas Medicine, Inc.
Editas Medicine, Inc. BiotechnologyHealth Technology Manufactures gene editing medicines | Health Technology |
Standards Coordinating Body
Standards Coordinating Body The Standards Coordinating Body is a nonprofit organization focused on accelerating the development, awareness, and implementation of standards and best practices in regenerative medicine, gene and cell therapies, and cell-based drug discovery. The private company is based in Gaithersburg, MD. It engages stakeholders such as government agencies, researchers, manufacturers, clinicians, and industry suppliers to identify, prioritize, and advance standards that improve the consistency, quality, safety, and efficacy of regenerative medicine products. The organization facilitates collaboration through project working groups that develop feasibility studies, standards drafts, white papers, and coordinate data generation activities in areas including cell therapy, gene therapy, tissue engineering, and cell-based drug discovery. It offers specialized educational programs and resources, such as training on FDA-recognized ISO cell counting standards, an interactive database of standards, and educational materials. | |
Chroma Medicine, Inc.
Chroma Medicine, Inc. Pharmaceuticals: MajorHealth Technology Manufactures genomic medicines | Health Technology |
- Stock Market
- Insiders
- Vic Myer
















